Laurel Wealth Advisors (North Carolina)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-150
| Closed | -$8K | – | 705 |
|
|
2021
Q4 | $8K | Hold |
150
| – | – | ﹤0.01% | 437 |
|
|
2021
Q3 | $6K | Hold |
150
| – | – | ﹤0.01% | 463 |
|
|
2021
Q2 | $6K | Hold |
150
| – | – | ﹤0.01% | 531 |
|
|
2021
Q1 | $5K | Hold |
150
| – | – | ﹤0.01% | 513 |
|
|
2020
Q4 | $5K | Hold |
150
| – | – | ﹤0.01% | 490 |
|
|
2020
Q3 | $4K | Hold |
150
| – | – | ﹤0.01% | 449 |
|
|
2020
Q2 | $4K | Hold |
150
| – | – | ﹤0.01% | 444 |
|
|
2020
Q1 | $2K | Hold |
150
| – | – | ﹤0.01% | 481 |
|
|
2019
Q4 | $5K | Hold |
150
| – | – | ﹤0.01% | 446 |
|
|
2019
Q3 | $1K | Hold |
150
| – | – | ﹤0.01% | 505 |
|
|
2019
Q2 | $2K | Hold |
150
| – | – | ﹤0.01% | 490 |
|
|
2019
Q1 | $2K | Hold |
150
| – | – | ﹤0.01% | 465 |
|
|
2018
Q4 | $2K | Buy |
+150
| New | +$2K | ﹤0.01% | 470 |
|